One unfortunate aspect of the collapse of the libel action is that this information will remain secret – at least until Dr Wakefield’s appearance before the GMC (now scheduled for July). Nevertheless, Dr Wakefield’s libel volte face is a dramatic vindication of Deer and his carefully documented exposure of the anti-MMR campaign.
The LSC’s disclosures confirm that the major beneficiaries of the anti-MMR litigation (payments were made from 1992 up to 2004) were the lawyers. They received some two thirds of the £15million total (£8million to solicitors, £1.7million to barristers). The bulk of the revenues accruing to solicitors went to the Manchester-based firm Alexander Harris, where one partner, Richard Barr, played the leading role in coordinating the anti-MMR campaign from the outset. Barr also pursued the claims of alleged victims of the use of organophosphates in farming and of former soldiers with Gulf War syndrome (with equal lack of success). He has subsequently left Alexander Harris and has apparently abandoned the anti-MMR cause.
The LSC provides a detailed account of how a further £4.2million was claimed in ‘fees and expenses’ by more than 60 experts retained by the lawyers in the quest to justify their claim for damages against the vaccine manufacturers by proving a link between MMR and autism. The key payments – amounting to a total of nearly £1.7million - went to around a dozen prominent campaign supporters (6). In principle, expert witnesses are supposed to provide objective evidence to the courts. In practice, it is clear that, in the case of the anti-MMR litigation, legal aid funding went largely to those supportive of the anti-MMR campaign.
The notion that serious science could result from research sponsored by legal aid funding and administered by lawyers is nonsense. The team of experts assembled by Barr did not include a single recognised autism specialist, paediatrician, vaccine specialist, virologist or paediatric gastroenterologist who has a current public appointment or is currently in practice. (Indeed, many of the experts have long retired, though several have embarked on new careers as professional expert witnesses.) When the LSC finally called a halt to the litigation in September 2003, it belatedly acknowledged that ‘in retrospect, it was not effective or appropriate for the LSC to fund research’, conceding that ‘the courts are not the place to prove new medical truths’ (7).
To any observer not familiar with the world of law, what is striking is the sheer scale of the payments received by the witnesses in this case, which contrasts sharply with standard incomes in the medical and scientific world. To enable a rough comparison, in the UK in the 1990s, the basic income of a mid-career researcher at a university or medical school would have been around £50,000 to £60,000 a year; a clinical psychologist would earn perhaps £30,000 to £40,000. What emerges is a cultural gulf between the largely public sector worlds of medicine and science, on the one hand – with low incomes, austere working conditions, meetings in shabby hospital or university seminar rooms, with institutional tea and sandwiches – and, on the other hand, the glitzy world of the law, in which highly paid professionals meet in luxury hotels with lavish hospitality and everybody claims handsome expenses (and after some quibbling, the LSC pays up).
Dr Wakefield received a total of more than £400,000 for his contribution to the case (equivalent to several times his annual income in the 1990s). He claims that he charged at the rates recommended by the British Medical Association for such work (between £47 and £100 per hour) (8). If he worked full time at this rate, his receipts would cover between two and four years exclusively devoted to the case. (Indeed, he indicates that his final award from the LSC was £100,000 less than he claimed.) Yet he was employed by the Royal Free up to December 2001, when he was reported to have taken up a post at Dr Jeff Bradstreet’s treatment centre in Florida (he has since moved on to another private clinic in Texas). According to Dr Wakefield, he donated the income he received from the litigation to support the foundation of a research unit dedicated to bowel problems in autistic children, first (unsuccessfully) at the Royal Free and later in the USA. According to Deer, the accounts of these organisations reveal that he was a recipient of funds from them rather than a donor.
The biggest single earner from the litigation was Professor John O’Leary who set up the firm Unigenetics to process requests from parents to test bowel and other specimens for traces of measles virus that Dr Wakefield believed would confirm his MMR-autism hypothesis. Indeed, the publication in 2002 of two papers by O’Leary’s team purporting to demonstrate measles fragments in autistic children appeared to many parents – though not to sceptical experts – to provide powerful evidence for the Wakefield theory. Two recent papers have conclusively refuted O’Leary’s findings (1,2). The recognition by the LSC that it could not rely on the results from O’Leary’s laboratory was one of the key factors in its decision to abandon the litigation. These tests ultimately failed to confirm a link between MMR and autism in a single child and left more than a thousand families with dashed hopes. Professor O’Leary and his colleagues received more than £700,000. No further publications in this field have emerged from his department.
Though the detailed figures have not previously been available, it has long been known that Dr Wakefield and Professor O’Leary had derived a substantial income from the litigation. Perhaps the most valuable revelation in the LSC’s recent document concerns payments to a number of individuals who have provided Dr Wakefield with vital public backing at key moments in the unfolding controversies surrounding MMR over the past decade. Many of these Wakefield supporters had not declared that they were beneficiaries of the litigation, though this might be considered a significant factor.
Dr Kenneth Aitken (£230,000) was formerly a clinical psychologist at Edinburgh children’s hospital but now works in private practice. He is closely associated with the burgeoning world of autism quackery in Scotland (9). He supported the Wakefield position at one of the Medical Research Council investigations and at the Scottish Executive inquiry in 2001. Dr Carol Stott (£100,000) was engaged on postgraduate research in autism in Cambridge before her suspension for sending abusive emails to Brian Deer. She has collaborated with Dr Wakefield on a number of articles published in anti-vaccine journals and runs a pro-Wakefield website. She has recently been appointed ‘associate professor’ at Dr Wakefield’s new clinic in Texas.
Dr Peter Fletcher (£40,000) was head of the committee on safety of medicines in the 1970s and emerged from retirement to endorse Dr Wakefield’s critique of MMR safety in 2001. He is regularly quoted by anti-MMR journalists, but refuses to speak to anybody critical of the Wakefield campaign. Dr Peter Harvey (£10,000) was an adult neurologist at the Royal Free who examined the children in Dr Wakefield’s Lancet study. He subsequently took early retirement and now has a practice in Harley Street providing expert testimony in relation to litigation claims. He has provided occasional endorsement for Dr Wakefield’s claims in the press and on television.
Mr Paul Shattock (£8,000) is the parent of an autistic son and a retired lecturer in pharmacy who provides urine tests of no known scientific value purporting to provide a guide to dietary treatments for autism from his HQ in the University of Sunderland. He is a long-standing public promoter of the Wakefield campaign. Dr Richard Halvorsen is a private GP in central London who runs a business selling measles, mumps and rubella as separate vaccines to parents rendered fearful of the triple jab by the anti-MMR campaign (of which he is a vocal supporter). He received only £6,000 from the litigation. However, a clinic just north of London providing a similar service was at one time reported to have a turnover of £17,500 a week (though it is now defunct since its proprietor, Dr David Pugh, was imprisoned for fraud in 2005 and struck off the medical register last year).
What emerges from these documents is that there does not appear to be a single professional supporter of the Wakefield campaign who was not also a beneficiary of the anti-MMR litigation. If Dr Wakefield’s British supporters appear a rather undistinguished bunch, they are paragons of professional virtue and integrity by comparison with Dr Wakefield’s US backers, such as Drs Bradstreet (£22,000), Krigsman (£17,000) and Geier (£7,000) (10).
It is not surprising that Brian Deer has attracted hostility from Dr Wakefield and his supporters. It is sad that he has also been denounced by a few parent campaigners who continue to regard Dr Wakefield as a hero. In truth Deer has emerged as a forceful champion of families affected by autism by exposing the truth about a campaign that has caused enormous distress to parents of children with autism as well as provoking unwarranted anxieties about MMR. While leading autism specialists and organisations have been largely ineffectual and much of the media (from Private Eye to the Daily Mail, from the Telegraph to BBC Radio 4’s Today programme) has been duped by Wakefield at one time or another, Deer has provided an invaluable service by revealing how much cash and cynicism has surrounded the campaign against MMR.
Much relevant documentation can be found on Brian Deer’s website and further background on the anti-MMR litigation and the personalities involved is provided in my book, MMR and Autism: What Parents Need To Know, published by Routledge, 2004.
Dr Michael Fitzpatrick is a GP and author of MMR and Autism: What Parents Need to Know (buy this book from Amazon (UK) or Amazon (USA)).
(1) Afzal MA, ‘Absence of detectable measles virus genome sequence in blood of autistic children who have had their MMR vaccination during the routine childhood immunization schedule of UK’, J Med Virol, 2006; 78:623-630 (March 2006)
(2) Yasmin D’Souza, Eric Fombonne, Brian J Ward, ‘No Evidence of Persisting Measles Virus in Peripheral Blood Mononuclear Cells From Children With Autism Spectrum Disorder’, Pediatrics, 2006; 118 (4):1664-1675 (October 2006)
(3) See the Brian Deer website
(4) See the Brian Deer website
(5) See the Brian Deer website
(6) See the Brian Deer website
(7) See my book MMR and Autism, p113-117
(8) See the JABS website
(9) The trouble with autism-lit, by Dr Michael Fitzpatrick
(10) See MMR and Autism, Brian Deer’s website and, for a detailed and shocking account of the activities of Dr Mark Geier and his son David, professional anti-vaccine litigation advisers and promoters of quack treatments for autism, see the NeuroDiversity website.
For permission to republish spiked articles, please contact Viv Regan.